MATRIX PHARMACORP PRIVATE LTD (India) holds 229 active US FDA Type II Drug Master Files and 1 inactive, has DMF or CEP filings on record for 40 active ingredients, holds 2 active Type IV (excipient) Drug Master Files and is linked to 5 FDA-registered manufacturing sites. 2 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “MATRIX PHARMACORP PRIVATE LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/matrix-pharmacorp-private-ltd

Overview

MATRIX PHARMACORP PRIVATE LTD is an active pharmaceutical ingredient (API) supplier with 228 active FDA Type II Drug Master Files, covering ABACAVIR SULFATE USP; ABALOPARATIDE; ACYCLOVIR USP; ALENDRONATE SODIUM USP (TRIHYDRATE); ALLOPURINOL USP; ALMOTRIPTAN MALATE USP.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which MATRIX PHARMACORP PRIVATE LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

MATRIX PHARMACORP PRIVATE LTD holds 229 active (230 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • BRIGATINIBActive2026-09-03
  • SUGAMMADEX SODIUMActive2026-03-30
  • AVATROMBOPAG MALEATEActive2025-12-31
  • CABOTEGRAVIRActive2025-09-30
  • CABOTEGRAVIR SODIUMActive2025-09-29
  • SERTRALINE HYDROCHLORIDE USP (FORM-I)Active2025-09-26
  • PHENTOLAMINE MESYLATE USP (PROCESS II)Active2025-06-25
  • TAPINAROFActive2025-02-05
  • ALPRAZOLAM USP (FORM-III)Active2025-01-02
  • OLSALAZINE SODIUMActive2023-12-20
  • FELBAMATE USP (FEL)Active2023-12-01
  • DORAVIRINEActive2023-10-06
  • PAROXETINE HYDROCHLORIDE USP (HEMIHYDRATE)Active2023-09-29
  • SELEGILINEActive2023-09-27
  • BICTEGRAVIR SODIUMActive2022-09-16
  • TOFACITINIB CITRATEActive2021-12-15
  • TENOFOVIR ALAFERNAMIDE MONOFUMARATEActive2021-12-10
  • ABALOPARATIDEActive2021-12-03
  • IRON SUCROSEActive2020-12-17
  • BEDAQUILINE FUMARATEActive2020-12-14
  • EFINACONAZOLEActive2019-12-20
  • MESALAMINE USPActive2019-12-05
  • SODIUM FERRIC GLUCONATE COMPLEXActive2019-12-03
  • PLECANATIDEActive2019-11-27
  • CANAGLIFLOZIN HEMIHYDRATEActive2019-11-27
  • PYRAZINAMIDE USPActive2019-11-01
  • RIVAROXABAN USPActive2019-10-15
  • LEDIPASVIRActive2018-12-28
  • SUCROFERRIC OXYHYDROXIDEActive2018-12-27
  • APIXABANActive2018-12-19
  • LANTHANUM CARBONATE (PROCESS 2)Active2018-12-11
  • DIPHENOXYLATE HYDROCHLORIDE USPActive2018-11-30
  • IRON DEXTRANActive2018-11-27
  • DROXIDOPAActive2018-09-18
  • FERRIC CARBOXYMALTOSEActive2018-08-02
  • PLERIXAFOR USPActive2018-01-07
  • SINCALIDEActive2018-01-07
  • PONATINIB HYDROCHLORIDEActive2018-01-07
  • SUGAMMADEX SODIUMActive2018-01-07
  • REGADENOSONActive2018-01-07
  • ATROPINE SULFATE USPActive2017-12-27
  • VERAPAMIL HYDROCHLORIDE USPActive2017-12-22
  • PALBOCICLIBActive2017-12-21
  • LEUPROLIDE ACETATE USPActive2017-12-19
  • MAFENIDE ACETATE USPActive2017-12-19
  • CHLORTHALIDONE USPActive2017-12-13
  • SACUBITRIL/VALSARTANActive2017-12-07
  • APREMILAST (CRYSTALLINE)Active2017-11-08
  • SOFOSBUVIRActive2017-09-01
  • VORTIOXETINE HYDROBROMIDEActive2017-06-24

Showing the 50 most relevant of 230 Drug Master Files (active first). The full list is in the FDA DMF list.

Excipient Drug Master Files

MATRIX PHARMACORP PRIVATE LTD holds 2 active (2 total) FDA Type IV Drug Master Files. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.

Registered manufacturing sites (5)

Physical sites registered with the US FDA and resolved to MATRIX PHARMACORP PRIVATE LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

2 FDA enforcement records linked to this company.

  • warning_letter2020-08-20

    FDA Warning Letter (drug product)

  • warning_letter2019-11-05

    FDA Warning Letter (drug product)

For suppliers

Is this MATRIX PHARMACORP PRIVATE LTD?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.